Company CVAbout Valiant Laboratories Ltd 
Valiant Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of `M/s. Bharat Chemicals' through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name "Valiant Laboratories Limited" through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 43.45 Cr
Number of Shares
4.34 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
04-Oct-2023
4.34
43.45
10890000
10
Public Issue
23-Feb-2023
3.26
32.56
16280000
10
Bonus Issue
28-Mar-2022
1.63
16.28
1480000
10
Bonus Issue
06-Feb-2022
1.48
14.80
4300000
10
Right Issues
16-Aug-2021
1.05
10.50
10500000
10
Subscriber to MOA
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 1 FIIs (0.0%)
Promoter with highest holding
Dhanvallabh Ventures Llp (46.84%)
Highest Public shareholder
Jainam Broking Limited (1.27%)
Individual Investors Holdings
17.55%
Board of Directors
Management
Designation
Remuneration
Velji Gogri
Chairman & Independent Directo
50.0 k
Santosh S. Vora
Managing Director
12.0 lacs
Shantilal Shivji Vora
Director
14.8 lacs
Paresh Shashikant Shah
Executive Director
15.0 lacs
Sonal A Vira
Independent Director
50.0 k
Sandeep Gupta..
Addtnl Non-Executive Director
0
Saloni Mehta
Company Sec. & Compli. Officer
4.3 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
35 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
Pharmaceuticals & Drugs
INR 412 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
-0.01
-4.31%
1.73
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
